Zeiher Bernhardt G
- SEC CIK
- 0001971421
In the past year, 1 open-market purchase filing worth $29.3K and no sales.
Current role at each company
- TRDA Entrada Therapeutics, Inc.Directoras of Jun 12, 2026
- AMLX Amylyx Pharmaceuticals, Inc.Directoras of Jun 8, 2026
- ABEO Abeona Therapeutics Inc.Directoras of Jan 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $29.3K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$29.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Zeiher Bernhardt G as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TRDA Entrada Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2026 (view filing) | May 20 | 1 day | Zeiher Bernhardt GDirector | PPurchase | +5.00K | $5.86 | +$29.3K | New position5.00K after |
AMLX Amylyx Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2025 (view filing) | Mar 20 | 4 days | Zeiher Bernhardt GDirector | PPurchase | +10.0K | $3.70 | +$37.0K | New position10.0K after |